HomeStock ScreenerMarkobenz VenturesIntrinsic Value

Markobenz Ventures Intrinsic Value

Markobenz Ventures (NEWTRAC) median intrinsic value is ₹8.38 from 3 valuation models (range ₹3–₹10), vs current price ₹4.19 — +100.0% upside (Trading Below Calculated Value), margin of safety 50.0%. Check NEWTRAC market value to track the company's total market size over time.

Market Price (CMP)
₹4.19
Primary Intrinsic Value
₹2.63
Market Cap
₹8.0 Cr
+100.0% Upside
Median Value
₹8.38
Value Range
₹3 - ₹10
Assessment
Trading Below Calculated Value
Safety Margin
50.0%

NEWTRAC Valuation Methods Summary — DCF, Graham Number & P/E

Markobenz Ventures intrinsic value across 3 models vs current price ₹4.19 — upside/downside and value range per method. See NEWTRAC price to book ratio to compare market price against book value per share.

Method Type Intrinsic Value Range Upside/Downside Details
Book Value Method asset ₹2.63 ₹2.37 - ₹2.89 -37.2% Book Value/Share: ₹2.63, P/B: 1.0x
Revenue Multiple Method revenue ₹8.38 ₹7.54 - ₹9.22 +100.0% Revenue/Share: ₹13.68, P/S: 0.8x
Simple DCF (5Y) dcf ₹9.77 ₹7.82 - ₹11.72 +133.2% CF Growth: 5.0%, Discount: 15%
Method Types: Earnings Asset DCF Growth Dividend Conservative

NEWTRAC Intrinsic Value vs Market Price — All Valuation Models

Markobenz Ventures fair value range ₹3–₹10 vs current market price ₹4.19 across 3 valuation models. For current market price and key ratios, visit NEWTRAC share price.

NEWTRAC Intrinsic Value Analysis — Undervalued or Overvalued?

Markobenz Ventures median intrinsic value ₹8.38, current price ₹4.19 — Trading Below Calculated Value by 100.0%, margin of safety 50.0%.

What is the intrinsic value of NEWTRAC?

Based on our comprehensive analysis using 3 different valuation methods, the estimated intrinsic value of Markobenz Ventures (NEWTRAC) is ₹8.38 (median value). With the current market price of ₹4.19, this represents a +100.0% variance from our estimated fair value.

The valuation range spans from ₹2.63 to ₹9.77, indicating ₹2.63 - ₹9.77.

Is NEWTRAC undervalued or overvalued?

Based on our multi-method analysis, Markobenz Ventures (NEWTRAC) appears to be trading below calculated value by approximately 100.0%.

NEWTRAC Financial Health — Key Ratios vs Industry Benchmarks

Markobenz Ventures financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Return on Equity -140.0% Industry Standard: 15%+ Below 10% Measures shareholder return efficiency
Operating Margin -52.0% Industry Standard: 20%+ Below 10% Indicates operational efficiency level
Asset Turnover Ratio 1.44x Industry Standard: 1.0x+ Above 1.0x Measures asset utilization efficiency

NEWTRAC Cash Flow Quality — Operating & Free Cash Flow

Markobenz Ventures operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2026 ₹2 Cr ₹0 Cr Positive Operating Cash Flow 6/10
March 2025 ₹-16 Cr ₹-16 Cr Negative Cash Flow 3/10
March 2024 ₹3 Cr ₹3 Cr Positive Free Cash Flow 8/10
March 2023 ₹0 Cr ₹0 Cr Negative Cash Flow 3/10
March 2022 ₹0 Cr ₹0 Cr Negative Cash Flow 3/10